Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedRecord history now displays the study as Completed with updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous Active, not recruiting label. New version/date entries accompany the update.SummaryDifference0.6%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThis updates the ClinicalTrials.gov interface version label from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a UI/release revision rather than a change to the trial record itself.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision (v3.5.0) was added and an existing revision (v3.4.3) was deleted from the history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating an internal site update. There is no evidence of changes to study data or user-facing content beyond the site’s revision history.SummaryDifference0.1%

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.